351
Participants
Start Date
May 31, 2006
Primary Completion Date
November 30, 2006
Study Completion Date
November 30, 2006
sumatriptan succinate/naproxen sodium
GSK Investigational Site, New York
GSK Investigational Site, New York
GSK Investigational Site, Carnegie
GSK Investigational Site, Philadelphia
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Mt. Pleasant
GSK Investigational Site, Port Orange
GSK Investigational Site, Sunrise
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Nashville
GSK Investigational Site, West Chester
GSK Investigational Site, Cincinnati
GSK Investigational Site, Cincinnati
GSK Investigational Site, South Bend
GSK Investigational Site, Ann Arbor
GSK Investigational Site, Chicago
GSK Investigational Site, Omaha
GSK Investigational Site, Baton Rouge
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Houston
GSK Investigational Site, San Antonio
GSK Investigational Site, Georgetown
GSK Investigational Site, Boulder
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Chandler
GSK Investigational Site, Albuquerque
GSK Investigational Site, Redondo Beach
GSK Investigational Site, Santa Monica
GSK Investigational Site, Irvine
GSK Investigational Site, San Francisco
GSK Investigational Site, Portland
GSK Investigational Site, Seattle
GSK Investigational Site, Toledo
GSK Investigational Site, Warwick
Lead Sponsor
GlaxoSmithKline
INDUSTRY